In these cases, the overexpression of ATGL or HSL by direct or indirect therapeutic means, could be detrimental for the patient, due to its association with cachexia, a multifactorial wasting syndrome in oncologic patients characterized by the uncontrolled loss of adipose tissue and muscle mass [114]. The gene discussed is LIPE; the disease is Cachexia.